Stay updated with breaking news from Meet nyt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Message : Required fields April 1 (Reuters) - Johnson & Johnson s manufacturing partner Emergent Biosolutions said on Thursday that it had discarded the single batch of COVID-19 drug substance that did not meet specifications. J&J on Wednesday said it had found a problem with a batch of the drug substance for its COVID-19 vaccine being produced at Emergent s site in Baltimore, Maryland. The New York Times reported on Wednesday that about 15 million doses were ruined, without citing a source. Discarding a batch of bulk drug substance, while disappointing, does occasionally happen during vaccine manufacturing, which is a complex and multi-step biological process, Emergent said. ....